Aligos TherapeuticsInc Stock Forecast - 20 Period Moving Average
| ALGS Stock | USD 0.80 0.05 6.67% |
The 20 Period Moving Average forecasted value of Aligos TherapeuticsInc on the next trading day is expected to be 0.94 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 4.59. Aligos Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Aligos TherapeuticsInc stock prices and determine the direction of Aligos TherapeuticsInc's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Aligos TherapeuticsInc's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Aligos TherapeuticsInc's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Aligos TherapeuticsInc's systematic risk associated with finding meaningful patterns of Aligos TherapeuticsInc fundamentals over time.
Check out Historical Fundamental Analysis of Aligos TherapeuticsInc to cross-verify your projections. Aligos |
Open Interest Against 2024-05-17 Aligos Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Aligos TherapeuticsInc's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Aligos TherapeuticsInc's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Aligos TherapeuticsInc stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Aligos TherapeuticsInc's open interest, investors have to compare it to Aligos TherapeuticsInc's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Aligos TherapeuticsInc is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Aligos. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Aligos TherapeuticsInc cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Aligos TherapeuticsInc's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Aligos TherapeuticsInc's price structures and extracts relationships that further increase the generated results' accuracy.
A commonly used 20-period moving average forecast model for Aligos TherapeuticsInc is based on a synthetically constructed Aligos TherapeuticsIncdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time. Aligos TherapeuticsInc 20 Period Moving Average Price Forecast For the 24th of April
Given 90 days horizon, the 20 Period Moving Average forecasted value of Aligos TherapeuticsInc on the next trading day is expected to be 0.94 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.02, and the sum of the absolute errors of 4.59.Please note that although there have been many attempts to predict Aligos Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Aligos TherapeuticsInc's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Aligos TherapeuticsInc Stock Forecast Pattern
| Backtest Aligos TherapeuticsInc | Aligos TherapeuticsInc Price Prediction | Buy or Sell Advice |
Aligos TherapeuticsInc Forecasted Value
In the context of forecasting Aligos TherapeuticsInc's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Aligos TherapeuticsInc's downside and upside margins for the forecasting period are 0.01 and 6.78, respectively. We have considered Aligos TherapeuticsInc's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Aligos TherapeuticsInc stock data series using in forecasting. Note that when a statistical model is used to represent Aligos TherapeuticsInc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 79.2805 |
| Bias | Arithmetic mean of the errors | -0.0547 |
| MAD | Mean absolute deviation | 0.1094 |
| MAPE | Mean absolute percentage error | 0.1176 |
| SAE | Sum of the absolute errors | 4.5935 |
Predictive Modules for Aligos TherapeuticsInc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aligos TherapeuticsInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aligos TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Aligos TherapeuticsInc
For every potential investor in Aligos, whether a beginner or expert, Aligos TherapeuticsInc's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aligos Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aligos. Basic forecasting techniques help filter out the noise by identifying Aligos TherapeuticsInc's price trends.Aligos TherapeuticsInc Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aligos TherapeuticsInc stock to make a market-neutral strategy. Peer analysis of Aligos TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Aligos TherapeuticsInc by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aligos TherapeuticsInc Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Aligos TherapeuticsInc's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Aligos TherapeuticsInc's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Aligos TherapeuticsInc Market Strength Events
Market strength indicators help investors to evaluate how Aligos TherapeuticsInc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aligos TherapeuticsInc shares will generate the highest return on investment. By undertsting and applying Aligos TherapeuticsInc stock market strength indicators, traders can identify Aligos TherapeuticsInc entry and exit signals to maximize returns.
| Accumulation Distribution | 40622.81 | |||
| Daily Balance Of Power | 0.7143 | |||
| Rate Of Daily Change | 1.07 | |||
| Day Median Price | 0.78 | |||
| Day Typical Price | 0.78 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | 0.05 |
Aligos TherapeuticsInc Risk Indicators
The analysis of Aligos TherapeuticsInc's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aligos TherapeuticsInc's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aligos stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.6 | |||
| Semi Deviation | 4.15 | |||
| Standard Deviation | 5.61 | |||
| Variance | 31.44 | |||
| Downside Variance | 29.11 | |||
| Semi Variance | 17.18 | |||
| Expected Short fall | (5.03) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aligos TherapeuticsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aligos TherapeuticsInc's short interest history, or implied volatility extrapolated from Aligos TherapeuticsInc options trading.
Pair Trading with Aligos TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aligos TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aligos TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving against Aligos Stock
| 0.46 | PCRX | Pacira Pharmaceuticals Financial Report 1st of May 2024 | PairCorr |
The ability to find closely correlated positions to Aligos TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aligos TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aligos TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aligos TherapeuticsInc to buy it.
The correlation of Aligos TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aligos TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aligos TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aligos TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Aligos TherapeuticsInc to cross-verify your projections. For more information on how to buy Aligos Stock please use our How to Invest in Aligos TherapeuticsInc guide.Note that the Aligos TherapeuticsInc information on this page should be used as a complementary analysis to other Aligos TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Aligos Stock analysis
When running Aligos TherapeuticsInc's price analysis, check to measure Aligos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos TherapeuticsInc is operating at the current time. Most of Aligos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Aligos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Aligos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Aligos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aligos TherapeuticsInc. If investors know Aligos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aligos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.242 | Quarterly Revenue Growth (0.24) | Return On Assets (0.37) | Return On Equity (0.89) |
The market value of Aligos TherapeuticsInc is measured differently than its book value, which is the value of Aligos that is recorded on the company's balance sheet. Investors also form their own opinion of Aligos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Aligos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aligos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Aligos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aligos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aligos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aligos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.